Department of Biomedicine, Division of Rheumatology, Denothe Centre, Careggi Hospital (AOUC), University of Florence, Villa Monna Tessa, viale Pieraccini 18, 50139 Firenze, Italy.
Rheumatol Int. 2012 Sep;32(9):2785-90. doi: 10.1007/s00296-011-2049-x. Epub 2011 Aug 17.
In systemic sclerosis (SSc), mouth and face involvement leads to problems in oral health-related quality of life (OHRQoL). Mouth Handicap in Systemic Sclerosis scale (MHISS) is a 12-item questionnaire specifically quantifying mouth disability in SSc, organized in 3 subscales. Our aim was to validate Italian version of MHISS, by assessing its test-retest reliability and internal and external consistency in Italian SSc patients. Forty SSc patients (7 dSSc, 33 lSSc; age and disease duration: 57.27 ± 11.41, 9.4 ± 4.4 years; 22 with sicca syndrome) were evaluated with MHISS. MHISS was translated following a forward-backward translation procedure, with independent translations and counter-translation. Test-retest reliability was evaluated, comparing the results of two administrations, with intraclass correlation coefficient (ICC). Internal consistency was assessed by Cronbach's α and external consistency by comparison with mouth opening. MHISS has a good test-retest reliability (ICC: 0.93) and internal consistency (Cronbach's α:0.99). A good external consistency was confirmed by correlation with mouth opening (rho: -0,3869, p: 0.0137). Total MHISS score was 17.65 ± 5.20, with scores of subscale 1 (reduced mouth opening) of 6.60 ± 2.85 and scores of subscales 2 (sicca syndrome) and 3 (aesthetic concerns) of 7.82 ± 2.59 and 3.22 ± 1.14. Total and subscale 2 scores are higher in dSSc than in lSSc. This result may be due to the higher presence of sicca syndrome in dSSc than in lSSc (p = 0.0109). Our results support validity and reliability in Italian SSc patients of MHISS, specifically measuring SSc OHRQoL.
在系统性硬化症(SSc)中,口腔和面部受累会导致口腔健康相关生活质量(OHRQoL)出现问题。系统性硬化症口腔残疾量表(MHISS)是一种专门用于量化 SSc 口腔残疾的 12 项问卷,分为 3 个亚量表。我们的目的是通过评估意大利语版 MHISS 在意大利 SSc 患者中的测试-重测信度、内部和外部一致性来验证其有效性。40 名 SSc 患者(7 名弥漫型 SSc,33 名局限型 SSc;年龄和病程:57.27±11.41 岁,9.4±4.4 年;22 名患者伴干燥综合征)接受 MHISS 评估。MHISS 采用前后翻译程序进行翻译,由独立翻译和反向翻译完成。通过计算组内相关系数(ICC)比较两次评估结果来评估测试-重测信度。通过 Cronbach's α评估内部一致性,通过与张口度比较评估外部一致性。MHISS 具有良好的测试-重测信度(ICC:0.93)和内部一致性(Cronbach's α:0.99)。通过与张口度的相关性验证,确认具有良好的外部一致性(rho:-0.3869,p:0.0137)。MHISS 总分为 17.65±5.20,亚量表 1(张口受限)得分为 6.60±2.85,亚量表 2(干燥综合征)和 3(美容问题)得分为 7.82±2.59 和 3.22±1.14。弥漫型 SSc 的总分和亚量表 2 得分均高于局限型 SSc。这一结果可能是由于弥漫型 SSc 中干燥综合征的发生率高于局限型 SSc(p=0.0109)。我们的研究结果支持意大利语版 MHISS 在意大利 SSc 患者中的有效性和可靠性,特别是用于评估 SSc OHRQoL。